Results 1 to 10 of about 120,291 (395)

Spinal muscular atrophy [PDF]

open access: goldOrphanet Journal of Rare Diseases, 2011
Spinal muscular atrophy (SMA) is an autosomal recessive neuromuscular disease characterized by degeneration of alpha motor neurons in the spinal cord, resulting in progressive proximal muscle weakness and paralysis. Estimated incidence is 1 in 6,000 to 1
D'Amico Adele   +3 more
doaj   +11 more sources

Advances and limitations for the treatment of spinal muscular atrophy

open access: yesBMC Pediatrics, 2022
Spinal muscular atrophy (5q-SMA; SMA), a genetic neuromuscular condition affecting spinal motor neurons, is caused by defects in both copies of the SMN1 gene that produces survival motor neuron (SMN) protein.
John W. Day   +6 more
doaj   +2 more sources

Biomarkers in spinal muscular atrophy [PDF]

open access: yesFrontiers in Neurology
Spinal muscular atrophy is a hereditary disorder leading to severe neuromuscular impairment. With the introduction of disease-modifying therapies in recent years, the role of biomarkers has expanded from aiding diagnosis to monitoring treatment responses,
Liping Yan   +3 more
doaj   +2 more sources

Rehabilitation management for patients with spinal muscular atrophy: a review [PDF]

open access: yesOrphanet Journal of Rare Diseases
The rehabilitation management of patients with spinal muscular atrophy is a complex, multidisciplinary process aimed at slowing disease progression, preventing complications, and enhancing patients’ quality of life.
Wei Song, Xiaohua Ke
doaj   +2 more sources

Emerging concepts underlying selective neuromuscular dysfunction in infantile-onset spinal muscular atrophy

open access: yesNeural Regeneration Research, 2021
Infantile-onset spinal muscular atrophy is the quintessential example of a disorder characterized by a predominantly neurodegenerative phenotype that nevertheless stems from perturbations in a housekeeping protein.
Kishore Gollapalli   +2 more
doaj   +1 more source

Spinal Muscular Atrophy: The Past, Present, and Future of Diagnosis and Treatment

open access: yesInternational Journal of Molecular Sciences, 2023
Spinal muscular atrophy (SMA) is a lower motor neuron disease with autosomal recessive inheritance. The first cases of SMA were reported by Werdnig in 1891.
H. Nishio   +5 more
semanticscholar   +1 more source

Oral risdiplam for specific therapy in adult patients with 5q spinal muscular atrophy in the Moscow region [PDF]

open access: yesАнналы клинической и экспериментальной неврологии, 2023
5q spinal muscular atrophy (SMA) is a rare autosomal recessive neuromuscular disease characterized by gradual loss of motor neurons with progressive muscle weakness and atrophy.
Ekaterina S. Novikova
doaj   +1 more source

Continued benefit of nusinersen initiated in the presymptomatic stage of spinal muscular atrophy: 5‐year update of the NURTURE study

open access: yesMuscle and Nerve, 2023
NURTURE (NCT02386553) is an open‐label study of nusinersen in children (two SMN2 copies, n = 15; three SMN2 copies, n = 10) who initiated treatment in the presymptomatic stage of spinal muscular atrophy (SMA).
T. Crawford   +24 more
semanticscholar   +1 more source

Base editing rescue of spinal muscular atrophy in cells and in mice

open access: yesScience, 2023
Spinal muscular atrophy (SMA), the leading genetic cause of infant mortality, arises from survival motor neuron (SMN) protein insufficiency resulting from SMN1 loss.
Mandana Arbab   +16 more
semanticscholar   +1 more source

Home - About - Disclaimer - Privacy